GITR costimulator (Bristol-Myers Squibb)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGITR costimulator (Bristol-Myers Squibb)
Drug Alias Nameanti-GITR antibodies (Bristol-Myers Squibb)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionGlucocorticoid-induced tumor necrosis factor receptor-related protein agonists
TargetsGlucocorticoid-induced tumor necrosis factor receptor-related protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A